Vitamin C and gout

Not Applicable

Completed

• Conditions: Gout; Musculoskeletal - Other muscular and skeletal disorders; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12610000545066
• Lead Sponsor: Associate Professor Lisa Stamp

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-07-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Gout as defined by American Rheumatology Association (ARA) preliminary classification criteria and a serum urate of >0.36mmol/

Exclusion Criteria

Patients taking regular vitamin supplements will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in serum urate[Week 4 and week 8 following randomisation]

Secondary Outcome Measures

Name	Time	Method
Increase in plasma vitamin C and/or plasma oxypurinol[Week 4 and week 8 following randomisation]